Abstract:MYOD is an E-box sequence-specific basic Helix-Loop-Helix (bHLH) transcriptional activator that, when expressed in non-muscle cells, induces nuclear reprogramming toward skeletal myogenesis by promoting chromatin accessibility at previously silent loci. Here, we report on the identification of a previously unrecognized property of MYOD as repressor of gene expression, via E-box-independent chromatin binding within accessible genomic elements, which invariably leads to reduced chromatin accessibility. MYOD-mediated repression requires the integrity of functional domains previously implicated in MYOD-mediated activation of gene expression. Repression of mitogen- and growth factor-responsive genes occurs through promoter binding and requires a highly conserved domain within the first helix. Repression of cell-of-origin/alternative lineage genes occurs via binding and decommissioning of distal regulatory elements, such as super-enhancers (SE), which requires the N-terminal activation domain as well as two chromatin-remodeling domains and leads to reduced strength of CTCF-mediated chromatin interactions. Surprisingly, MYOD-mediated chromatin compaction and repression of transcription do not associate with reduction of H3K27ac, the conventional histone mark of enhancer or promoter activation, but with reduced levels of the recently discovered histone H4 acetyl-methyl lysine modification (Kacme). These results extend MYOD biological properties beyond the current dogma that restricts MYOD function to a monotone transcriptional activator and reveal a previously unrecognized functional versatility arising from an alternative chromatin recruitment through E-box or non-E-box sequences. The E-box independent repression of gene expression by MYOD might provide a promiscuous mechanism to reduce chromatin accessibility and repress cell-of-origin/alternative lineage and growth factor/mitogen-responsive genes to safeguard the integrity of cell identity during muscle progenitor commitment toward the myogenic lineage.

Proteomic and Functional Analyses Reveal the Role of Chromatin Reader SFMBT1 in Regulating Epigenetic Silencing and the Myogenic Gene Program*

The Malignant Brain Tumor (MBT) Domain Protein SFMBT1 Is an Integral Histone Reader Subunit of the LSD1 Demethylase Complex for Chromatin Association and Epithelial-to-mesenchymal Transition

A Novel Zinc Finger Protein Zfp637 Behaves As a Repressive Regulator in Myogenic Cellular Differentiation.

Exploring high-resolution chromatin interaction changes and functional enhancers of myogenic marker genes during myogenic differentiation

HRP2–DPF3a–BAF Complex Coordinates Histone Modification and Chromatin Remodeling to Regulate Myogenic Gene Transcription

The Msx1 Homeoprotein Recruits G9a Methyltransferase to Repressed Target Genes in Myoblast Cells

Histone H3 Methyltransferase Suv39h1 Prevents Myogenic Terminal Differentiation By Repressing Mef2 Activity In Muscle Cells

BMI1 Fine-Tunes Gene Repression and Activation to Safeguard Undifferentiated Spermatogonia Fate.

Histone methltransferase MLL4 controls myofiber identity and muscle performance through MEF2 interaction

A Proteomic Approach Identifies SAFB-like Transcription Modulator (SLTM) As a Bidirectional Regulator of GLI Family Zinc Finger Transcription Factors

Interactive regulation of DNA demethylase gene<i> TET1</i> and m6A methyltransferase gene<i> METTL3</i> in myoblast differentiation

E-box independent chromatin recruitment turns MYOD into a transcriptional repressor

L3MBTL1, a histone-methylation-dependent chromatin lock.

Bioinformatics analysis of Myelin Transcription Factor 1

MYT1L is required for suppressing earlier neuronal development programs in the adult mouse brain

Genome-Wide Analysis of MAMSTR Transcription Factor-Binding Sites via ChIP-Seq in Porcine Skeletal Muscle Fibroblasts

Histone methyltransferase MLL4 controls myofiber identity and muscle performance through MEF2 interaction

Regulation of Heterochromatin Remodelling and Myogenin Expression During Muscle Differentiation by FAK Interaction with MBD2

Characterization and Perturbation of CTCF-mediated Chromatin Interactions for Enhancing Myogenic Transdifferentiation.

Genome-wide binding analysis unveils critical implication of B-Myb-mediated transactivation in cancers

Whole transcriptome profiling reveals a lncMDP1 that regulates myogenesis by adsorbing miR-301a-5p targeting CHAC1